Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$209.01 - $232.56 $9,823 - $10,930
47 Added 4.47%
1,099 $240,000
Q4 2023

Feb 07, 2024

BUY
$197.69 - $227.29 $3,163 - $3,636
16 Added 1.54%
1,052 $239,000
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $2,412 - $2,660
12 Added 1.17%
1,036 $208,000
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $27,338 - $31,131
-129 Reduced 11.19%
1,024 $247,000
Q1 2023

May 05, 2023

BUY
$213.32 - $257.83 $4,693 - $5,672
22 Added 1.95%
1,153 $264,000
Q4 2022

Feb 10, 2023

SELL
$203.72 - $248.97 $15,075 - $18,423
-74 Reduced 6.14%
1,131 $266,000
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $7,782 - $9,963
38 Added 3.26%
1,205 $247,000
Q2 2022

Aug 11, 2022

BUY
$213.86 - $277.87 $9,623 - $12,504
45 Added 4.01%
1,167 $306,000
Q1 2022

May 09, 2022

BUY
$259.82 - $298.18 $10,652 - $12,225
41 Added 3.79%
1,122 $296,000
Q4 2021

Feb 09, 2022

SELL
$271.6 - $314.21 $8,148 - $9,426
-30 Reduced 2.7%
1,081 $340,000
Q3 2021

Nov 09, 2021

BUY
$274.82 - $308.34 $5,221 - $5,858
19 Added 1.74%
1,111 $313,000
Q2 2021

Aug 06, 2021

SELL
$251.87 - $278.14 $14,608 - $16,132
-58 Reduced 5.04%
1,092 $301,000
Q1 2021

May 10, 2021

SELL
$204.88 - $255.03 $8,400 - $10,456
-41 Reduced 3.44%
1,150 $293,000
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $16,448 - $18,868
88 Added 7.98%
1,191 $242,000
Q3 2020

Nov 10, 2020

BUY
$167.03 - $201.3 $184,234 - $222,033
1,103 New
1,103 $208,000
Q4 2018

Feb 07, 2019

SELL
$120.82 - $174.09 $145,346 - $209,430
-1,203 Closed
0 $0
Q3 2018

Oct 29, 2018

BUY
$167.67 - $188.27 $4,862 - $5,459
29 Added 2.47%
1,203 $209,000
Q2 2018

Aug 06, 2018

BUY
$160.33 - $189.41 $188,227 - $222,367
1,174 New
1,174 $211,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.